title: Another case of reversibility of visual-field defect induced by vigabatrin monotherapy: is young age a favorable factor?
authors.forename: L
authors.initials: L
authors.lastname: Giordano
authors.forename: D
authors.initials: D
authors.lastname: Valseriati
authors.forename: A
authors.initials: A
authors.lastname: Vignoli
authors.forename: F
authors.initials: F
authors.lastname: Morescalchi
authors.forename: E
authors.initials: E
authors.lastname: Gandolfo
mesh_terms: D000293:Adolescent; D000927:Anticonvulsants / Q000009:adverse effects*; D004828:Epilepsies, Partial / Q000188:drug therapy*; D005260:Female; D006801:Humans; D020888:Vigabatrin / Q000009:adverse effects*; D014786:Vision Disorders / Q000139:chemically induced*; D014794:Visual Fields / Q000187:drug effects*
chemical_list: D000927:Anticonvulsants; D020888:Vigabatrin